Cardiac MR Imaging of Nonischemic Cardiomyopathies

Magnetic Resonance Imaging Clinics of North America

Volumn 16, Issue 2, 2008, Pages 165-183

  Harris, Scott R ^a   Glockner, James ^a   Misselt, Andrew J ^a   Syed, Imran S ^a   Araoz, Philip A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy; Delayed enhancements; MR imaging

Indexed keywords

CARDIOMYOPATHY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; GENETIC SCREENING; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IRON OVERLOAD; LONGEVITY; LYME DISEASE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SARCOIDOSIS; SUDDEN DEATH; SYNCOPE; TAKOTSUBO CARDIOMYOPATHY; VENTRICULAR NONCOMPACTION;

CARDIOMYOPATHIES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 43249086573     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2008.02.010     Document Type: Review

References (50)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 5 (1996) 841-842
2. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and Council on Epidemiology and Prevention. Circulation 113 14 (2006) 1807-1816
3. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 9 (2003) 1687-1713
4. Nathan AW, SID. Essential cardiology. 3rd edition. London: Blackwell; 1997.
5. Bogaert J., and Taylor A.M. Nonischemic myocardial disease. In: Bogaert J., Dymarkowski S., and Taylor A.M. (Eds). Clinical cardiac MRI (2005), Springer Verlag Inc., New York (NY) p. 285-304
6. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 12 (2002) 2156-2164
7. Moon J.C., McKenna W.J., McCrohon J.A., et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 9 (2003) 1561-1567
8. Dumont C.A., Monserrat L., Soler R., et al. Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 60 1 (2007) 15-23 [in Spanish]
9. Dec G.W., and Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 331 23 (1994) 1564-1575
10. Knaapen P., Gotte M.J., Paulus W.J., et al. Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. Radiology 240 2 (2006) 380-388
11. Hare J.M. The dilated, restrictive, and infiltrative cardiomyopathies. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th edition (2007), Saunders, St. Louis (MO) p. 1739-60
12. Wu E., Judd R.M., Vargas J.D., et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 9249 (2001) 21-28
13. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 1 (2003) 54-59
14. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 10 (2004) 1250-1258
15. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 10 (2006) 1977-1985
16. Corrado D., Basso C., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 83 5 (2000) 588-595
17. Fontaine G., Fontaliran F., and Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 97 16 (1998) 1532-1535
18. Kayser H.W., van der Wall E.E., Sivananthan M.U., et al. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 22 3 (2002) 639-648 [discussion: 649-50]
19. Castillo E., Tandri H., Rodriguez E.R., et al. Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology 232 1 (2004) 38-48
20. Ferrari V.A., and Scott C.H. Arrhythmogenic right ventricular cardiomyopathy: time for a new look. J Cardiovasc Electrophysiol 14 5 (2003) 483-484
21. Sen-Chowdhry S., Lowe M.D., Sporton S.C., et al. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 117 9 (2004) 685-695
22. Bomma C., Rutberg J., Tandri H., et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 15 3 (2004) 300-306
23. McKenna W.J., Thiene G., Nava A., et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task force of the working group myocardial and pericardial disease of the European society of cardiology and of the scientific council on cardiomyopathies of the international society and federation of cardiology. Br Heart J 71 3 (1994) 215-218
24. Basso C., Thiene G., Corrado D., et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?. Circulation 94 5 (1996) 983-991
25. Tandri H., Saranathan M., Rodriguez E.R., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45 1 (2005) 98-103
26. Weiford B.C., Subbarao V.D., and Mulhern K.M. Noncompaction of the ventricular myocardium. Circulation 109 24 (2004) 2965-2971
27. Ritter M., Oechslin E., Sutsch G., et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 72 1 (1997) 26-31
28. Boyd M.T., Seward J.B., Tajik A.J., et al. Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol 9 2 (1987) 323-326
29. Petersen S.E., Selvanayagam J.B., Wiesmann F., et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46 1 (2005) 101-105
30. Oechslin E.N., Attenhofer Jost C.H., Rojas J.R., et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36 2 (2000) 493-500
31. Kohli S.K., Pantazis A.A., Shah J.S., et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?. Eur Heart J 29 1 (2008) 89-95
32. Jenni R., Oechslin E.N., and van der Loo B. Isolated ventricular non-compaction of the myocardium in adults. Heart 93 1 (2007) 11-15
33. Henke C.E., Henke G., Elveback L.R., et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 123 5 (1986) 840-845
34. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122 6 (2002) 1895-1901
35. Uemura A., Morimoto S., Hiramitsu S., et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138 2 Pt 1 (1999) 299-302
36. Smedema J.P., Snoep G., van Kroonenburgh M.P., et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128 3 (2005) 1629-1637
37. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184 1 (2005) 249-254
38. *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 23 (2001) 2171-2179
39. * cardiovascular magnetic resonance imaging. Tex Heart Inst J 32 3 (2005) 448-449
40. Hassan W., Al-Sergani H., Mourad W., et al. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J 32 2 (2005) 178-184
41. Shah K.B., Inoue Y., and Mehra M.R. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 166 17 (2006) 1805-1813
42. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 2 (2005) 186-193
43. Mahrholdt H., Wagner A., Judd R.M., et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 15 (2005) 1461-1474
44. Feldman A.M., and McNamara D. Myocarditis. N Engl J Med 343 19 (2000) 1388-1398
45. Laissy J.P., Messin B., Varenne O., et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 122 5 (2002) 1638-1648
46. Gagliardi M.G., Bevilacqua M., Di Renzi P., et al. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 68 10 (1991) 1089-1091
47. Laissy J.P., Hyafil F., Feldman L.J., et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 237 1 (2005) 75-82
48. Gilles A., Antoine M., Vincent J.L., et al. Peripartum cardiomyopathy. Rev Med Brux 22 5 (2001) 436-438 [in French]
49. Ogbogu P.U., Rosing D.R., and Horne III M.K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27 3 (2007) 457-475
50. Syed I.S., Martinez M.W., Feng D.L., et al. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 29 (2007)